FDA Drafts Guidance on Replacing Reagents for IVD Devices Post author:Sam Post published:February 15, 2018 Post category:The GMP Letter The FDA issued draft guidance to provide updates on in vitro diagnostics’ replacement reagents. Source: The GMP Letter You Might Also Like Firm Cited for Neglecting MDR Reporting Patient Death March 3, 2016 FDA Issues Update on Pilot Accreditation Scheme for Conformity Assessments February 7, 2020 Canada Issues New Premarket Requirements for Cybersecurity August 15, 2019